Failed takeover bid takes toll on Adcock
The healthcare company has posted a loss in the wake of a failed stock offer.
Adcock Ingram
PIC wants local ownership to boost economy
The Public Investment Corporation, South Africa’s biggest stock investor, says local ownership is key for growing the economy and empowering people.
Shareholders join the battle over Adcock Ingram
The gloves came off this week as two companies and a dominant shareholder battled it out for control of the pharmaceutical company Adcock Ingram.
CFR: Opposition to Adcock offer is to deter foreign buyers
The drawn-out battle for Adcock now sees CFR’s offer for Adcock now facing resistance from the PIC, which says the offer is not up to scratch.
Bidvest sues Adcock over CFR deal finance
A day after putting in an offer to acquire part of Adcock Ingram, Bidvest is taking the company to court over an "unlawful" guarantee.
Adcock rebuffs Bidvest, still wants Chile deal
Drugmaker Adcock Ingram says the $1.2-billion takeover bid from CFR Pharmaceuticals is still the best option, despite Bidvest’s offer.
Bidvest attempts to torpedo $1.2bn Adcock takeover
A Chilean group’s $1.2-billion bid for Adcock Ingram has been challenged by a court action from Bidvest.
Bidvest bids R4-billion for Adcock to counter CFR
Bidvest has put in a R4-billion offer for pharmaceuticals company Adcock, countering that of Chilean company CFR Pharmaceuticals.
Adcock suspends its dividend as purchase talks with CFR go on
Rising import costs led to decreased profits and margins at Adcock, which has suspended its dividend while takeover talks with CFR continue.
PIC still mulling Adcock’s $1.3bn CFR deal
The pharmaceutical company Adcock’s biggest shareholder PIC says it has not yet made a decision about whether to support the takeover of CFR.
Decision on Adcock offer imminent, says CFR
Chile’s largest drugmaker will decide within weeks whether to make a binding offer for Adcock Ingram Holdings.
SA could score 40% of Adcock, CFR deal
Adcock Ingram has entered into discussions with a Chile-based firm, which could see SA benefit from a possible combined revenue of R12.1-billion.
Adcock profit slides as talks to buy the drugmaker continue
The pharmaceuticals giant has reported its’ profit fell 5.4% as it continues takeover talks that may lead to the company being bought.
Adcock takeover offer may push company value to $1.5bn
Adcock Ingram, SA’s largest supplier of hospital products, may gain a further 12% from a 30-month high after it got takeover offers.
Drug wars: How Adcock saw its Aspen
A tale of two companies — one saw generics as the future, the other is playing catch-up.
No image available
Adcock Ingram vs MCC: A worrying legal battle
Adcock Ingram’s battle with the MCC over Synap Forte and similar drugs has cast doubt on the state attorney’s capacity to handle legal challenges.
No image available
Urgent bid to stop the sale of ‘toxic’ meds
The Medicines Control Council has obtained an urgent court order to stop the continued sale of potentially deadly medicines.
No image available
Adcock sees lower full-year profit; shares fall
SA’s second-biggest drug maker expects full-year profit to fall due to BEE once-off charge.
No image available
Adcock full-year profit up, unveils BEE deal
Adcock Ingram posted a 16,1% rise in full-year profit bolstered by volumes growth and price increases and said it expected further volume growth.
No image available
Adcock posts rise in earnings
Adcock Ingram posted a 4,6% rise in full-year headline earnings per share on Tuesday, and said its core businesses had remained resilient.
No image available
Tiger slaps its own wrist
Executives are walking away with millions for keeping quiet. Lloyd Gedye reports.
No image available
Tiger Brands shareholders approve Adcock listing
Shareholders of Tiger Brands on Thursday approved resolutions that will give rise to the separate listing and unbundling of Adcock Ingram Holdings.
No image available
Call to make price-fixing illegal
The recent National Anti-Corruption Summit supported moves to make price-fixing a crime — despite opposition from the Competition Commission.
No image available
Packaging error causes antiretroviral recall
Pharmaceutical company Adcock Ingram urgently recalled two batches of its antiretroviral products on Friday due to a packaging error.
No image available
Tiger Brands to sell Adcock interest
Tiger Brands said on Monday it had reached agreement to sell 50% plus one share of its unit Adcock Ingram Critical Care to Baxter Healthcare.
No image available
Tiger execs make a killing
How Tiger Brand bosses bailed out while selling R44-million in shares.
No image available
Govt awards antiretrovirals tender
The awarding of a new tender for antiretroviral drugs by the Health Department will mean important savings for the state’s treatment programme.
No image available
Tribunal confirms Adcock fine
The Competition Tribunal on Monday confirmed the consent order agreement between the Competition Commission and respondents Adcock Ingram Critical Care, Dismed Criticare, Thusanong Healthcare and Tiger Brands. Last month Adcock Ingram admitted liability for colluding on prices and agreed to pay an administrative penalty of R53,5-million.
